Related Experiment Video

Updated: May 3, 2026

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
06:44

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells

Published on: March 1, 2024

1.9K

B-RAF and its novel negative regulator reticulocalbin 1 (RCN1) modulates cardiomyocyte hypertrophy

Nadine Kramann1, Gerd Hasenfuß, Tim Seidler

  • 1Department of Cardiology and Pulmonology, University Medical Centre Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.

Cardiovascular Research
|February 5, 2014
PubMed
Abstract

Insights

Inhibition of B-RAF kinase activity prevents cardiac hypertrophy. Reticulocalbin 1 (RCN1) acts as a novel negative regulator, blocking this hypertrophic response in cardiomyocytes.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cell Signaling

Background:

  • RAF kinase activation and downstream signaling contribute to cardiomyocyte hypertrophy.
  • B-RAF is hypothesized to be a key activator of MEK signaling in various cell types.

Purpose of the Study:

  • To investigate the role of B-RAF in cardiomyocyte hypertrophy.
  • To identify factors that modulate B-RAF activity in the context of cardiac hypertrophy.

Main Methods:

  • Utilized a B-RAF inhibitor (SB590885) to block B-RAF activity in neonatal rat cardiomyocytes stimulated to induce hypertrophy.
  • Employed a dual-luciferase reporter assay for B-RAF activity measurement in a cDNA expression screen.
  • Investigated the effects of reticulocalbin 1 (RCN1) overexpression and knockdown using adenovirus-mediated delivery.

Main Results:

  • Specific B-RAF inhibition completely abolished phenylephrine-induced cardiomyocyte hypertrophy and reduced MEK1/2 phosphorylation.
  • RCN1 was identified as a novel negative modulator of B-RAF activity.
  • Overexpression of RCN1 impeded hypertrophy and decreased MEK1/2 phosphorylation, while RCN1 knockdown induced hypertrophy and increased MEK1/2 phosphorylation.

Conclusions:

  • B-RAF kinase activity is essential for cardiac hypertrophy.
  • RCN1 is a newly identified negative regulator that abolishes cardiomyocyte hypertrophic responses by inhibiting the mitogen-activated protein kinase signaling cascade.
Keywords:
B-RAFCardiomyocyte hypertrophyMAPKRCN1Reticulocalbin 1

More Related Videos

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

8.0K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

5.7K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K